Comparative assessment of nanomaterial definitions and safety evaluation considerations

Regulatory Toxicology and Pharmacology

Volumn 73, Issue 1, 2015, Pages 137-150

  Boverhof, Darrell R ^a   Bramante, Christina M ^b   Butala, John H ^c   Clancy, Shaun F ^d   Lafranconi, William M ^e   West, Jay ^f   Gordon, Steve C ^g  

^a DOW CHEMICAL COMPANY   (United States)

^b CABOT CORPORATION   (United States)

^c Toxicology Consultants Inc   (United States)

^d Evonik Degussa Corporation   (United States)

^e Tox Horizons   (United States)

^f AMERICAN CHEMISTRY COUNCIL   (United States)

^g 3M COMPANY   (United States)

Author keywords

Definitions; Nanomaterial; Risk evaluation

Indexed keywords

NANOMATERIAL;

ARTICLE; COMMERCIAL PHENOMENA; CONTROLLED STUDY; ENVIRONMENTAL IMPACT; GOVERNMENT; HEALTH HAZARD; INDUSTRY; NANOTECHNOLOGY; ORGANIZATION; PARTICLE SIZE; PRIORITY JOURNAL; SAFETY; SOLUBILITY; WEIGHT; ADVERSE EFFECTS; CHEMISTRY; COMPARATIVE STUDY; DEVICE MATERIAL; ENVIRONMENTAL HEALTH; HUMAN; PROCEDURES; RISK ASSESSMENT;

ENVIRONMENTAL HEALTH; HUMANS; MANUFACTURED MATERIALS; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; RISK ASSESSMENT; SAFETY;

EID: 84936996244     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.06.001     Document Type: Article

References (81)

1. ACC Comments Submitted in Response to: Pesticides; Policies Concerning Products Containing Nanomaterials; OpportunA-HQ-OPP-20ity for Public Comment (EP10-0197) 2011, American Chemistry Council, Available at:, Accessed 14.01.14. http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2010-0197-0179.
2. ACC Responsible Care 2014, American Chemistry Council, Available at:, Accessed 14.01.14. http://responsiblecare.americanchemistry.com.
3. Akaighe N., MacCuspie R., Navarro D., Aga D., Banerjee S., Sohn M., Sharma V. Humic acid-induced silver nanoparticle formation under environmentally relevant conditions. Environ. Sci. Technol. 2011, 45:3895-3901.
4. ANSES Ministry of Ecology, Sustainable Development, Transportation, and Housing. Decree no. 2012-232 of 17 February 2012 on the annual declaration on substances at nanoscale in application of article R. 523-4 of the Environment code. Off. J. Fr. Repub. 19 February 2012, Text 4/44. Available at:, Accessed 14.11.13. https://www.r-nano.fr/?locale=en.
5. Auffan M., Rose J., Bottero J.Y., Lowry G.V., Jolivet J.P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 2009, 4:634-641.
6. Belgium Royal Decree Concerning the Placing on the Market of Substances Produced in Nanoparticular State 2014, Federal Public Service Health, Food Chain Safety and Environment, Kingdom of Belgium.
7. Bermudez E., Mangum J.B., Wong B.A., Asgharian B., Hext P.M., Warheit D.B., Everitt J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 2004, 77:347-357.
8. Bleeker E.A., de Jong W.H., Geertsma R.E., Groenewold M., Heugens E.H., Koers-Jacquemijns M., van de Meent D., Popma J.R., Rietveld A.G., Wijnhoven S.W., Cassee F.R., Oomen A.G. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul. Toxicol. Pharmacol. 2013, 65:119-125.
9. Borm P., Klaessig F.C., Landry T.D., Moudgil B., Pauluhn J., Thomas K., Trottier R., Wood S. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol. Sci. 2006, 90:23-32.
10. Brinker C., Hurd A., Schunk P., Frye G., Ashley C. Review of sol-gel thin film formation. J.Non-Cryst. Solids 1992, 147:424-436.
11. 60) formed using two procedures. Environ. Sci. Technol. 2005, 39:6343-6351.
12. Brown S.C., Boyko V., Meyers G., Voetz M., Wohlleben W. Toward advancing nano-object count metrology: a best practice framework. Environ. Health Perspect. 2013, 121:1282-1291.
13. Buzea C., Pacheco I.I., Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2:MR17-172.
14. Creutzenberg O., Bellmann B., Korolewitz R., Koch W., Mangelsdorf I., Tillmann T., Schaudien D. Change in agglomeration status and toxicokinetic fate of various nanoparticles invivo following lung exposure in rats. Inhal. Toxicol. 2012, 24:821-830.
15. Davis J.M. The role of clearance and dissolution in determining the durability or biopersistence of mineral fibers. Environ. Health Perspect. 1994, 102(Suppl.5):113-117.
16. Denmark Order on a Register of Mixtures and Articles that Contain Nanomaterials as Well as the Requirement for Producers and Importers to Report to the Register 2014, Danish Environmental Protection Agency Statutory, Order no. 644 of 13 June 2014.
17. Donaldson K., Poland C.A. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr. Opin. Biotechnol. 2013, 24:724-734.
18. Donnet J., Bansal R.C., Wang M.J. Carbon Black 1993, Marcel Dekker, Inc., New York.
19. Durães L., Benedini L., Costa B., Portugal A. Sol-gel synthesis and washing of amorphous g-FeO (OH) xerogels. Mater. Werkst. 2012, 43:427-434.
20. EC (2009).European Commission Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Off. J. Eur. Union (EN) 12 December 2009, 52:59-209. L342.
21. EC European Commission. Commission Recommendation of 18 October 2011 on the definition of nanomaterials. Off. J. Eur. Union (EN) 2011, 54:38-40. 20 October 2011. L275.
22. EC European Commission. Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 Ocboer 2011 on the provision of food information to consumers, amending Regulations (EC) No 1924/2006 and (EC) no 1925/2006 of the European Aprliament and of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC, Directive 2000/13/EC of the European Parliament of the the Council, Commission Directives 2002/67/EC and 2008/5/EC and Commission Regulation (EC) No 608/2004. Official J. Eur. Union (EN) 2011, 18-63. 22 November 2011. L304.
23. EC (2012).European Commission Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products. Off. J. Eur. Union (EN) 27 June 2012, 1-123. L167.
24. Environmantal Defense Fund and Dupont NANO Risk Framework 2007, Available at:, Accessed 19.05.15. http://www.nanoriskframework.com.
25. Fruijtier-Polloth C. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. Toxicology 2012, 294:61-79.
26. Fu S.Y., Feng X.Q., Lauke B., Mai Y.W. Effects of particle size, particle/matrix interface adhesion and particle loading on mechanical properties of particulate-polymer composites. Compos. Part B: Eng. 2008, 39:933-961.
27. Galeone A., Vecchio G., Malvindi M.A., Brunetti V., Cingolani R., Pompa P.P. Invivo assessment of CdSe-ZnS quantum dots: coating dependent bioaccumulation and genotoxicity. Nanoscale 2012, 4:6401-6407.
28. Gordon S.C., Butala J.H., Carter J.M., Elder A., Gordon T., Gray G., Sayre P.G., Schulte P.A., Tsai C.S., West J. Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials. Reg. Tox. Pharm. 2014, 68:305-311.
29. Gray C.A., Muranko H. Studies of robustness of industrial aciniform aggregates and agglomerates: carbon black and amorphous silicas: a review amplified by new data. J.Occup. Environ. Med. 2006, 48:1279-1290.
30. Gulson B., McCall M., Korsch M., Gomez L., Casey P., Oytam Y., Taylor A., McCulloch M., Trotter J., Kinsley L., Greenoak G. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol. Sci. 2010, 118:140-149.
31. Hamburg M.A. FDA's approach to regulation of products of nanotechnology. Science 2012, 336:299-300.
32. Hardman R. Atoxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 2006, 114:165-172.
33. Health Canada Policy Statement on Health Canada's Working Definition for Nanomaterials 2011, Avaialble at, Accessed 14.11.13. http://www.hc-sc.gc.ca/sr-sr/pubs/nano/pol-eng.php.
34. Ho M., Wu K.Y., Chein H.M., Chen L.C., Cheng T.J. Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhal. Toxicol. 2011, 23:947-956.
35. Hochella M.F., Lower S.K., Maurice P.A., Penn R.L., Sahai N., Sparks D.L., Twining B.S. Nanominerals, mineral nanoparticles, and earth systems. Science 2008, 319:1631-1635.
36. Höck J., Epprecht T., Furrer E., Gautschi M., Hofmann H., Höhener K., Knauer K., Krug H., Limbach L., Gehr P., Nowack B., Riediker M., Schirmer K., Schmid K., Som C., Stark W., Studer C., Ulrich A., von Götz N., Weber A., Wengert S., Wick P. Guidelines on the Precautionary Matrix for Synthetic Nanomaterials 2013, Federal Office of Public Health and Federal Office for the Environment, Berne, Version 3.0. Available at:, Accessed 18 May 2015. http://www.bag.admin.ch/nanotechnologie/12171/12174/index.html?lang=en.
37. Holdren J.P. Memorandum for the Heads of Executive Departments and Agencies: Policy Principles for the U.S. Decision-making Concerning Regulation and Oversight of Application of Nanotechnology and Nanomaterials June 9, 2011, Available at:, Accessed 10.01.14. http://www.whitehouse.gov/sites/default/files/omb/inforeg/for-agencies/nanotechnology-regulation-and-oversight-principles.pdf.
38. Horst A.M., Vukanti R., Priester J.H., Holden P.A. An assessment of fluorescence- and absorbance-based assays to study metal-oxide nanoparticle ROS production and effects on bacterial membranes. Small 2013, 9:1753-1764.
39. ICCA Core Elements of a Regulatory Definition of Manufactured Nanomaterials 2010, International Council of Chemical Associations, Available at:, Accessed 10.01.14. http://www.icca-chem.org/ICCADocs/Oct-2010_ICCA-Core-Elements-of-a-Regulatory-Definition-of-Manufactured-Nanomaterials.pdf?epslanguage=en.
40. ICCA Responsible Care 2014, International Council of Chemical Associations, Accessed 14.01.14. http://www.icca-chem.org/en/Home/Responsible-care/.
41. ISO International Organization for Standardization. Technical Specification: Nanotechnologies-terminology and Definitions for Nano-objects-Nanoparticle, Nanofibre and Nanoplate 2008, ISO/TS 80004-2:2008.
42. ISO International Organization for Standardization. Nanotechnologies-vocabulary-part 1: Core Terms 2010, ISO/TS 80004-1:2010.
43. JRC Joint Research Center. Towards a Review of the EC Recommendation for a Definition of the Term "nanomaterial" Part 2: Assessment of Collected Information Concerning the Experience with the Definition 2014, EUR 26744 EN. Avaialble at:, Accessed 19.05.15. https://ec.europa.eu/jrc/sites/default/files/jrc_nm-def_report2_eur26744.pdf.
44. Knieke C., Berger A., Voigt M., Taylor R.N.K., Röhrl J., Peukert W. Scalable production of graphene sheets by mechanical delamination. Carbon 2010, 48:3196-3204.
45. Linsinger T.P.J., Roebben G., Gilliland D., Calzolai L., Rossi F., Gibson N., Klein C. Requirements on Measurements for the Implementation of the European Commission of the Term "nanomaterial" 2012, European Commission Joint Research Centre, Reference Report. Report EUR 25404 EN.
46. Lopes S., Ribeiro F., Wojnarowicz J., Lojkowski W., Jurkschat K., Crossley A., Soares A.M., Loureiro S. Zinc oxide nanoparticles toxicity to Daphnia magna: size-dependent effects and dissolution. Environ. Toxicol. Chem. 2014, 33:190-198.
47. Luther W. Industrial Application of Nanomaterials - Chances and Risks 2004, Technology Analysis, Future Technologies Division of VDI Technologiezentrum GmbH, No. 54, Dusseldorf.
48. Maier M., Hannebauer B., Holldorff H., Albers P. Does lung surfactant promote disaggregation of nanostructured titanium dioxide?. J.Occup. Environ. Med. 2006, 48:1314-1320.
49. Maynard A.D. Don't define nanomaterials. Nature 2011, 475:31.
50. NICNAS Australian Government, Department of Health, National Industrial Chemicals Notification and Assessment Scheme 2010, Chemical Gazette of 5 October 2010. Available at:, Accessed 14.11.13. http://www.nicnas.gov.au/communications/publications/chemical-gazette/chemical-gazette-archive.
51. Norway Environment Agency What Chemicals Must Be Reported? 2014, Available at:, Accessed 18.05.15. http://www.miljodirektoratet.no/no/Tema/Kjemikalier/Produktregisteret/The_Product_Register/What-Chemicals-Must-Be-Reported/.
52. Oberdörster G. Dosimetric principles for extrapolating results of rat inhalation studies to humans, using an inhaled Ni compound as an example. Health Phys. 1989, 57(Suppl.1):213-220.
53. Oberdörster G., Ferin J., Lehnert B.E. Correlation between particle size, invivo particle persistence, and lung injury. Environ. Health Perspect. 1994, 102(Suppl.5):173-179.
54. OECD Report of the OECD Workshop on the Safety of Manufactured Nanomaterials: Building Co-operation, Co-ordination and Communication 2006, Organisation for Economic Co-operation and Development, ENV/JM/MONO(2006)19. 28 April 2006.
55. OECD Preliminary Review of OECD Test Guidelines for Their Applicability to Manufactured Nanomaterials 2009, Organisation for Economic Co-operation and Development, ENV/JM/MONO(2009)21. 10 July 2009.
56. OECD Important Issues on Risk Assessment of Manufactured Nanomaterials 2012, Organisation for Economic Co-operation and Development, ENV/JM/MONO(2012)8. 28 March 2012.
57. OECD Co-Operation on Risk Assessment: Prioritisation of Important Issues on Risk Assessment of Manufactured Nanomaterials 2013, Organisation for Economic Co-operation and Development, Final Report. ENV/JM/MONO(2013)18. 21 August 2013.
58. OECD Recommendation of the Council on the Safety Testing and Assessment of Manufactured Nanomaterials 2013, Organisation for Economic Co-operation and Development, C(2013)107. 19 September 2013.
59. Oomen A.G., Bos P.M., Fernandes T.F., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., von der Kammer F., Kuhnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment: report of the NanoSafety Cluster Working Group 10. Nanotoxicology 2014, 8:334-348.
60. Pauluhn J. Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): the key metric of dose is particle mass and not particle surface area. Toxicology 2009, 259:140-148.
61. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 2010, 113:226-242.
62. Petersen E.J., Henry T.B., Zhoa J., MacCuspie R.I., Kirschling T.L., Dobrovolskaia M.A., Hackley V., Xing B., White J.C. Identification and avoidance of potential artifacts in nanomaterial ecotoxicity measurements. Environ. Sci. Technol. 2014, 48:4226-4246.
63. Rauscher H., Ansell J., Araki D., Bronaugh R., Ikarashi Y., Lefebvre M.-A., Ogasawara H., Suwa T., Tayabali A.F., Tooley I., Yasuda N. ICCR Working Group: Characterization of Nanomaterials II - Insolubility, Biopersistence and Size Measurement in Complex Meida 2012, International Cooperation on Cosmetic Regulations, ICCR/NANOCHAR1/R/FINAL/. Available at:, Accessed 01.05.15. http://iccrnet.org/topics/.
64. SCCS Guidance on the Safety Assessment of Nanomaterials in Cosmetics 2012, Scientific Committee on Consumer Safety, Available at:, Accessed 08.04.15. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_005.pdf.
65. SCENIHR Opinion on the Appropriateness of the Risk Assessment Methodology in Accordance with the Technical Guidance Documents for New and Existing Substances for Assessing the Risks of Nanomaterials. 21-22 June 2007 2007, Scientific Committee on Emerging and Newly-Identified Health Risks.
66. Slezakova K., Morais S., Pereira M.C. Atmospheric nanoparticles and their impacts on public health. Current Topics in Public Health 2013, InTech, Chapter 23, Available from:. http://www.intechopen.com/books/current-topics-in-public-health/atmospheric-nanoparticles-and-their-impacts-on-public-health, A. Rodriguez-Morales (Ed.).
67. Slowey A. Rate of formation and dissolution of mercury sulfide nanoparticles: the dual role of natural organic matter. Geochim. Cosmochim. Acta 2010, 74:4693-4708.
68. Stamm H. Risk factors: nanomaterials should be defined. Nature 2011, 476:399.
69. Stoeger T., Reinhard C., Takenaka S., Schroeppel A., Karg E., Ritter B., Heyder J., Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ. Health Perspect. 2006, 114:328-333.
70. Taiwan Guidance for Supplementary Existing Chemical Substance Nomination (SECN) 2012, Taiwan Council of Labor Affairs. first ed.
71. Taurozi J., Hackley V., Wiesner M. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment: issues and recommendations. Nanotoxicology 2011, 5:711-729.
72. Comparison of number and respirable mass concentration determinations. Advances in Air Sampling. American Conference of Governmental Industrial Hygienists 1988, Lewis Publishers, Chelsea, MI. T. Tomb, R. Haney (Eds.).
73. Tsuji J.S., Maynard A.D., Howard P.C., James J.T., Lam C.W., Warheit D.B., Santamaria A.B. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol. Sci. 2006, 89:42-50.
74. US EPA Nanotechnology White Paper 2007, U.S. Environmental Protection Agency, EPA 100/B-07/001. Accessed 14.11.13 at. http://www.epa.gov/osa/pdfs/nanotech/epa-nanotechnology-whitepaper-0207.pdf.
75. US EPA Pesticides; policies concerning products containing nanoscale materials; opportunity for public comment. Fed. Regist. 17 June 2011, 76(14):35383-35395. (2011a).
76. US EPA U.S. Environmental Protection Agency. Proposed significant new use rules on certain chemical substances. Fed. Regist. 28 December 2011, 76(249):81441-81447. (2011b).
77. US EPA U.S. Environmental Protetion Agency. Chemical substances when manufactured or processed as nanoscale materials; TSCA reporting and recordkeeping requirements. Fed. Regist. 6 April 2014, 80(65):18330-18342. (2014).
78. US FDA Considering Whether an FDA-regulated Product Involves the Application of Nanotechnology: Guidance for Industry: Draft Guidance 2011, U.S. Food and Drug Administration, Available at:, Accessed 14.11.13. http://www.fda.gov/RegulatoryInformation/Guidances/ucm257698.htm.
79. Wittmaack K. In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what?. Environ. Health Perspect. 2007, 115:187-194.
80. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
81. Young S. Overview of Sol-Gel Science and Technology January 2002, (2002), Army Research Laboratory, Maryland, ARL-TR-2650.